Form 4 for OLMA Olema Pharmaceuticals, Inc.
Accepted 2024-01-16 00:00:00 ET · period of report 2024-01-12 · accession 0001415889-24-001062 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2024-01-16 | 2024-01-12 | OLMA | Kovacs Shane William Charles | CH. OPERATING, FINANCIAL OFF | M - OptEx | $7.02 | +50.0K | 485.0K | +11% | +$351.0K |
| D | 2024-01-16 | 2024-01-12 | OLMA | Kovacs Shane William Charles | CH. OPERATING, FINANCIAL OFF | M - OptEx | $0.00 | -50.0K | 187.0K | -21% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2024-01-12 | M | A | 50,000 | $7.02 | 484,987 | D | — | — | |
| 2 | Derivative | Stock Option (Right to Buy) | 2024-01-12 | M | D | 50,000 | $0.00 | 187,000 | D | $7.02 · — to 2032-01-31 | 50,000 Common Stock | (F1) 25% of the shares subject to the option vested on February 1, 2023 and 1/48 of the total number of shares subject to the option vest each month thereafter, subject to the Reporting Person's continuous service through each applicable vesting date. |